Australia
🎯 Global Pharma Leader | Transforming Organisations | Portfolio Strategy | Biotech Innovation I’m a senior executive with 20+ years of global experience driving innovation, operational excellence, and strategic growth across pharmaceutical and biotech industries. Having led high-value R&D portfolios, built and scaled global project management functions, transformed critical parts of organisations, and accelerated development timelines across Europe and the U.S., I now bring that expertise to Australia. My leadership has spanned high-impact roles at companies like Ferring Pharmaceuticals, CureVac, Sandoz, and Novartis, where I’ve: - Delivered first-in-class FDA approvals and biotech turnarounds, - Orchestrated cross-functional programs involving R&D, Commercial, Medical Affairs, and Regulatory, - Managed budgets of 400M+ AUD and led global teams of 150+ in matrix setups. I thrive at the intersection of science, strategy, and execution — transforming innovative science into patient-ready solutions, faster. Whether guiding startups through their first asset strategy or helping mature organizations re-energize portfolio pipelines & excel in execution, I bring a global lens with a local commitment.
Strategic sabbatical after two decades in pharmaceutical executive leadership, focused on world exploration, relocation to Australia, and full-time parenting while preparing for the next transformational leadership role in the pharmaceutical and biotech industry.
Led development operations & portfolio management of global R&D assets. Led a department of project & portfolio management and PMO across US, DK and CH sites. Directed and executed 5-year business operational and 10-year strategic plans.
Led global R&D operations and oversaw the gene therapy uro-oncology development program. Successfully achieved first-in-class US FDA approval for the product in 2022.
Executive MBA at top-tier European Business School IMD - International Institute for Management Development in Lausanne, Switzerland